Sanofi-aventis Amerique Du Nord S.n.c. - Net Worth and Insider Trading

Sanofi-aventis Amerique Du Nord S.n.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sanofi-aventis Amerique Du Nord S.n.c. owns 1 companies in total, including Regeneron Pharmaceuticals Inc (REGN) .

Click here to see the complete history of Sanofi-aventis Amerique Du Nord S.n.c.’s form 4 insider trades.

Insider Ownership Summary of Sanofi-aventis Amerique Du Nord S.n.c.

Ticker	Comapny	Transaction Date	Type of Owner
REGN	Regeneron Pharmaceuticals Inc	2007-12-20	10 percent owner

Sanofi-aventis Amerique Du Nord S.n.c. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sanofi-aventis Amerique Du Nord S.n.c. Ownership Network

Ownership Network List of Sanofi-aventis Amerique Du Nord S.n.c.

No Data

Ownership Network Relation of Sanofi-aventis Amerique Du Nord S.n.c.

Sanofi-aventis Amerique Du Nord S.n.c. Owned Company Details

What does Regeneron Pharmaceuticals Inc do?

Who are the key executives at Regeneron Pharmaceuticals Inc?

Sanofi-aventis Amerique Du Nord S.n.c. is the 10 percent owner of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .

Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary

Over the past 18 months, Sanofi-aventis Amerique Du Nord S.n.c. made no insider transaction in Regeneron Pharmaceuticals Inc (REGN). Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 9,914 shares made by Marion Mccourt , a net sale of 1,500 shares made by Arthur F Ryan , and a net sale of 9,158 shares made by Bonnie L Bassler .

In summary, during the past 3 months, insiders sold 36,273 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 36,273 shares. During the past 18 months, 326,467 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 326,467 shares.

Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regeneron Pharmaceuticals Inc Insider Transactions

No Available Data

Sanofi-aventis Amerique Du Nord S.n.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Sanofi-aventis Amerique Du Nord S.n.c.. You might contact Sanofi-aventis Amerique Du Nord S.n.c. via mailing address: 174, Avenue De France, Paris I0 75013.

Discussions on Sanofi-aventis Amerique Du Nord S.n.c.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.